week 8 counseling points

mannitol

• Indication(s): Used to reduce increased intracranial pressure

• Note(s): Use a filter for administration; inspect for crystals

acetazolamide

• Indication(s): metabolic alkalosis

diphenhydramine

• Side effect(s): May cause drowsiness, strong anticholinergic effects

levothyroxine

• Warning(s): Decrease dose in cardiovascular disease

• Monitor: TSH levels and clinical symptoms every 4-6 weeks until levels are normal

• Note(s): IV to PO ratio is 0.75:1

sodium polystyrene sulfonate

• Indication(s): Hyperkalemia

• Warning(s): GI necrosis; can bind other oral medications

glycopyrrolate

Indication(s): Used to reduce secretions

dornase alfa

Indication(s): Used for cystic fibrosis; off-label: used in combination with thrombolytic (alteplase) for intrapleural effusions

dantrolene

Indication(s): Malignant hyperthermia

methylene blue

BBW: May cause serious or fatal serotonin syndrome when administered with serotonergic drugs and opioids.

Indication(s): Treatment of acquired methemoglobinemia.

meperidine

Indication(s): Used off-label for postoperative rigors (shivering);